Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17728158 | 0.86 | ALDH1A1 (0.46) | CYP2C19ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL3165671 | 0.83 | CYP2C19 (0.52) | CYP2C19ALDH1A1LMNAELANEMAPT | |
| SCHEMBL3159498 | 0.82 | CYP2C19 (0.45) | CYP2C19ALDH1A1LMNAMAPTMAPK1 | |
| Styrene SCHEMBL16466837 | 0.82 | CYP2C19 (0.51) | CYP2C19ALDH1A1LMNAELANEMAPT | |
| SCHEMBL29061732 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL1520947 | 0.81 | ALDH1A1 (0.55) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL26130563 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL824126 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL11027749 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL27450314 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107427449-A | For improving the composition and method of skin appearance | 欧莱雅 | 2017-12-01 | — | — | CN | claimed |
| CN-105228701-B | The device of liquid lip composition comprising inverted emulsion form and porous application component | 莱雅公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-110101606-A | Liquid cosmetic composition | 莱雅公司 | 2019-08-09 | — | — | CN | disclosed |
| WO-2019028248-A1 | SYSTEMS AND METHODS FOR IMPROVING DELIVERY OF TOPICAL ACTIVES | YOUNG PHARMACEUTICALS, INC. (US) | 2019-02-07 | — | — | WO | disclosed |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2205197-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'Oreal (FR) | 2010-07-14 | — | — | EP | disclosed |
| US-20100009931-A1 | ASSOCIATION OF A TENSOR AGENT OR DEVICE AND A SACCHARIDE COMPOUND | L'OREAL (FR) | 2010-01-14 | — | — | US | disclosed |
| US-20090285770-A1 | Topical Compositions for Promoting Homeostasis of the Skin | L'OREAL (FR) | 2009-11-19 | — | — | US | disclosed |
| WO-2009056545-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2009-05-07 | — | — | WO | disclosed |
| US-20080305069-A1 | Cosmetic Use of Tensing Agents to Improve the Thickness of the Skin and/or the Radiance of the Complexion | L'OREAL (FR) | 2008-12-11 | — | — | US | disclosed |
| EP-1951191-A1 | TOPICAL COMPOSITIONS FOR PROMOTING HOMEOSTASIS OF THE SKIN | L'Oréal (FR) | 2008-08-06 | — | — | EP | disclosed |
| EP-1951378-A1 | COSMETIC USE OF TENSING AGENTS TO IMPROVE THE THICKNESS OF THE SKIN AND/OR THE RADIANCE OF THE COMPLEXION | L'Oréal (FR) | 2008-08-06 | — | — | EP | disclosed |
| US-20080181953-A1 | COMPOSITION CONTAINING A TENSIONING POLYMER AND HYBRID PARTICLES, METHODS OF USE | L'OREAL (FR) | 2008-07-31 | — | — | US | disclosed |
| US-20070166269-A1 | Cosmetic composition containing a statistical polymer with a linear chain of ethylenic nature | L'OREAL (FR) | 2007-07-19 | — | — | US | disclosed |
| WO-2007057452-A1 | COSMETIC USE OF TENSING AGENTS TO IMPROVE THE HOMEOSTASIS OF THE SKIN AND/OR THE RADIANCE OF THE COMPLEXION | L'ORÉAL (FR) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007057448-A1 | TOPICAL COMPOSITIONS FOR PROMOTING HOMEOSTASIS OF THE SKIN | L'ORÉAL (FR) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007057451-A1 | COSMETIC USE OF TENSING AGENTS TO IMPROVE THE THICKNESS OF THE SKIN AND/OR THE RADIANCE OF THE COMPLEXION | L'ORÉAL (FR) | 2007-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166269-A1 | Cosmetic composition containing a statistical polymer with a linear chain of ethylenic nature | POLH, LAGE3, ELOVL6 | CYP2C19 1081/4885ALDH1A1 3735/4885LMNA 239/4885 |
| US-20080181953-A1 | COMPOSITION CONTAINING A TENSIONING POLYMER AND HYBRID PARTICLES, METHODS OF USE | CUTA, COL14A1, SOST | CYP2C19 1641/4885ALDH1A1 4851/4885LMNA 376/4885 |
| US-20090285770-A1 | Topical Compositions for Promoting Homeostasis of the Skin | CUTA, PIEZO1, TSLP | CYP2C19 4822/4885ALDH1A1 3221/4885LMNA 2183/4885 |
| US-20100009931-A1 | ASSOCIATION OF A TENSOR AGENT OR DEVICE AND A SACCHARIDE COMPOUND | PIEZO1, TRPA1, TREH | CYP2C19 4531/4885ALDH1A1 1521/4885LMNA 3261/4885 |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | PHOSPHO1, CUTA, SGMS1 | CYP2C19 3801/4885ALDH1A1 4031/4885LMNA 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.